Attached files

file filename
10-K - 10-K - ACURA PHARMACEUTICALS, INCv212664_10k.htm
EX-32 - EX-32 - ACURA PHARMACEUTICALS, INCv212664_ex32.htm
EX-31.2 - EX-31.2 - ACURA PHARMACEUTICALS, INCv212664_ex31-2.htm
EX-31.1 - EX-31.1 - ACURA PHARMACEUTICALS, INCv212664_ex31-1.htm
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
Acura Pharmaceuticals, Inc.
Palatine, Illinois

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-151653, 333-151620, 333-133172, 333-123615, 333-63288, and 33-98356) and on Form S-3 (No. 333-146416) of Acura Pharmaceuticals, Inc. of our report dated March 1, 2011, relating to the consolidated financial statements.
 
/s/ BDO USA, LLP
Chicago, Illinois
March 1, 2011